DrFirst

DrFirst is a healthcare technology company that provides a range of software solutions aimed at improving medication management, care collaboration, and information accessibility for various stakeholders in the healthcare industry. The company's flagship offering, Rcopia, is an award-winning electronic prescribing (e-prescribing) solution that has processed over 1 billion medication transactions. Rcopia offers comprehensive access to medication history data and adherence support, making it ideal for handling both legend drug and controlled substance e-prescribing (EPCS) across diverse healthcare settings.

One of DrFirst's key innovations is the SmartSuite technology, which employs predictive analytics to optimize e-prescribing and reduce the need for pharmacy clarifications. Additionally, Rcopia provides extensive electronic patient medication histories, enhancing patient safety and streamlining medication reconciliation processes. The solution also incorporates comprehensive clinical alerts for drug-drug interactions and features like the PatientAdvisor toolbar to identify patients at risk of non-adherence and offer tools to improve compliance.

In April 2024, DrFirst acquired Myndshft Technologies, a leader in end-to-end real-time medical benefits and automated prior authorization (PA) software. This strategic acquisition aimed to improve patient access to specialty medications, such as infusions and in-office injectables primarily covered by medical benefits, while also lightening the administrative burden on healthcare providers.